Publication
Final results of a multicenter phase II clinical trial evaluating the activity of single-agent lapatinib in patients with HER2-negative metastatic breast cancer and HER2-positive circulating tumor cells. A proof-of-concept study
Marta Pestrin, Silvia Bessi, Fabio Puglisi, Alessandro M. Minisini, Giovanna Masci, Nicola Battelli, Alberto Ravaioli, Lorenzo Gianni, Roberta Di Marsico, Carlo Tondini, Stefania Gori, Charles R. Coombes, Justin Stebbing, Laura Biganzoli, Marc Buyse, Angelo Di Leo
Breast Cancer Research and Treatment, April 2012, Springer Science + Business Media
DOI: 10.1007/s10549-012-2045-1